A commentary by attorney at law, partner at BRACE Roman Shabrov was published in the magazine “Pharmaceutical Bulletin” on the topic of commercial policies of pharmaceutical companies: who needs them and what should be provided for in them.
A commentary by BRACE lawyer Anna Ivanova to the Pharmaceutical Herald magazine on the issue of legal regulation of donations from pharmaceutical companies has been published.
BRACE associate Anna Ivanova’s commentary was published in the article “How to Properly Design Sponsored Advertising for Pharmaceutical Companies”, published in the Pharmaceutical Bulletin magazine.
Considering the complexity of the issue of drafting and legal verification of foreign trade contracts, work on them will be carried out within the framework of a formed group with the involvement of lawyers of several specializations.
BRACE lawyer Anna Ivanova’s commentary was published in Ekaterina Pogontseva’s article “Samples Caught in the Crossfire”, published in the Pharmaceutical Bulletin magazine, on the issue of distributing medicinal product samples at specialized events for pharmaceutical and medical workers.
Among the most important changes in the regulation of the Russian pharmaceutical industry in the 2nd quarter of 2023, are the following:
:
Among the most important changes in the regulation of foreign economic activity in the 1st quarter of 2023, the following can be distinguished:
Among the most important changes in the regulation of the Russian pharmaceutical industry in the 1st quarter of 2023, the following can be distinguished:
Roman Shabrov, partner at BRACE commented for Pharmaceutical Bulletin magazine on the case of an anti-competitive agreement on the Chlorhexedine antiseptic market, identified by the FAS Russia, the resolution of which was appealed by the companies held liable.
In July 2021, the Eurasian Economic Commission issued an update that from July 1, 2021, medicinal products should be registered according to the unified rules of the EAEU. These rules were approved by the Decision of the Council of the Economic Commission dated 03.01.2017 No. 78 “On the rules for registration and examination of medicines for medical use”. At the same time, for the Russian Federation, the establishment of compulsory registration under the EAEU Rules was carried out from January 1, 2021.